Related Experiment Video
Updated: Aug 8, 2026

Massively Parallel Reporter Assays in Cultured Mammalian Cells
Published on: August 17, 2014
Role of PML and PML-RARalpha in Mad-mediated transcriptional repression
1Laboratory of Molecular Genetics, RIKEN Tsukuba Institute, 305-0074, Ibaraki, Japan.
Abstract:
Fusion of the promyelocytic leukemia (PML) protein to the retinoic acid receptor-alpha (RARalpha) generates the transforming protein of acute promyelocytic leukemias. PML appears to be involved in multiple functions, including apoptosis and transcriptional activation by RAR, whereas PML-RARalpha blocks these functions of PML. However, the mechanisms of leukemogenesis by PML-RARalpha remain elusive. Here we show that PML interacts with multiple corepressors (c-Ski, N-CoR, and mSin3A) and histone deacetylase 1, and that this interaction is required for transcriptional repression mediated by the tumor suppressor Mad. PML-RARalpha has the two corepressor-interacting sites and inhibits Mad-mediated repression, suggesting that aberrant binding of PML-RARalpha to the corepressor complexes may lead to abrogation of the corepressor function. These mechanisms may contribute to events leading to leukemogenesis.
Insights
The promyelocytic leukemia (PML) protein fused to retinoic acid receptor-alpha (RARalpha) drives leukemia. This study reveals PML-RARalpha disrupts normal PML function by interfering with corepressor complexes, potentially causing cancer.
Area of Science:
- Molecular Biology
- Cancer Biology
- Hematology
Background:
- Acute promyelocytic leukemia (APL) is characterized by the PML-RARalpha fusion protein.
- The precise mechanisms by which PML-RARalpha drives leukemogenesis are not fully understood.
- The promyelocytic leukemia (PML) protein plays roles in apoptosis and transcriptional regulation.
Purpose of the Study:
- To investigate the molecular mechanisms underlying PML-RARalpha-mediated leukemogenesis.
- To identify interactions between PML and corepressor complexes.
- To determine how PML-RARalpha affects the function of PML and associated proteins.
Main Methods:
- Co-immunoprecipitation assays to detect protein-protein interactions.
- Analysis of transcriptional repression mediated by the tumor suppressor Mad.
- Investigating the role of corepressor-binding sites in PML-RARalpha function.
Main Results:
- PML interacts with corepressors c-Ski, N-CoR, and mSin3A, along with histone deacetylase 1.
- This interaction is crucial for Mad-mediated transcriptional repression.
- PML-RARalpha possesses two corepressor-interacting sites and inhibits Mad-mediated repression.
- Aberrant binding of PML-RARalpha to corepressor complexes abrogates their function.
Conclusions:
- PML-RARalpha disrupts normal PML function by interfering with corepressor complexes.
- This disruption of corepressor function by PML-RARalpha is a potential mechanism contributing to leukemogenesis in APL.
- Targeting these aberrant interactions may offer therapeutic strategies for APL.
Related Concept Videos
MicroRNAs
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Master Transcription Regulators
Abnormal Proliferation
MicroRNAs

